Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    6357118 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
Condition: Colorectal Cancer
Interventions: Biological: BCG vaccine;   Biological: biological therapy;   Drug: fluorouracil;   Drug: semustine;   Drug: vincristine sulfate

Indicates status has not been verified in more than two years